Zealand Pharma A/S (LON:0NZU)
London
· Delayed Price · Currency is GBP · Price in DKK 407.77
+13.88 (3.52%)
At close: Apr 23, 2025
Zealand Pharma Revenue
In the year 2024, Zealand Pharma had annual revenue of 62.69M DKK, down -81.71%. Zealand Pharma had revenue of 9.06M in the quarter ending December 31, 2024, a decrease of -61.02%.
Revenue
62.69M DKK
Revenue Growth
-81.71%
P/S Ratio
473.61
Revenue / Employee
187.14K DKK
Employees
335
Market Cap
3.29B GBP
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62.69M | -280.10M | -81.71% |
| Dec 31, 2023 | 342.79M | 238.80M | 229.65% |
| Dec 31, 2022 | 103.99M | -4.56M | -4.20% |
| Dec 31, 2021 | 108.55M | -83.46M | -43.47% |
| Dec 31, 2020 | 192.00M | 150.67M | 364.52% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| Shell | 227.10B |
| HSBC Holdings | 48.93B |
| Unilever | 50.25B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |
| British American Tobacco p.l.c. | 25.87B |
| London Stock Exchange Group | 8.86B |